VERTEX PHARMACEUTICALS INC / MA ($VRTX)
Filing Information
| Accession Number | 0000875320-26-000088 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
7,313
Total Value
$2,289,666.28
P&L
+inf% (+$1,173,136.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | Common Stock | โ | Feb 17, 2026 | Grant/Award | 2,584 | $0.00 | $0.00 | 13,215 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Feb 17, 2026 | Tax Withholding | 1,110 | $483.75 | $536,962.50 | 12,105 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Feb 17, 2026 | Sale | 2,437 | $489.46 | $1,192,814.02 | 9,668 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Feb 18, 2026 | Sale | 1,182 | $473.68 | $559,889.76 | 8,486 | Direct | โ | View Details |